MNDR
Mobile-health·NASDAQ
--
--(--)
--
--(--)
2.55 / 10
Underperform
MNDR's fundamental assessment is weak, with a score of 2.55/10. Key concerns include a negative return on total assets of -7.69% and a Days sales outstanding in the first quartile, signaling collection inefficiencies. Although Inventory turnover days is favorable, the overall financial health is compromised, leading to a recommendation for selective investment only.
Analysis Checks(1/4)
Days sales outstanding
Value5.18
Score1/3
Weight6.60%
1M Return0.24%
Value5.18
Score1/3
Weight6.60%
1M Return0.24%
Annualized return on total assets (%)
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Rate of return on total assets (%)
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Inventory turnover days
Value7.57
Score3/3
Weight40.85%
1M Return1.44%
Value7.57
Score3/3
Weight40.85%
1M Return1.44%
Days sales outstanding
Value5.18
Score1/3
Weight6.60%
1M Return0.24%
Value5.18
Score1/3
Weight6.60%
1M Return0.24%
Rate of return on total assets (%)
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Annualized return on total assets (%)
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Value-7.69
Score1/3
Weight26.27%
1M Return0.99%
Inventory turnover days
Value7.57
Score3/3
Weight40.85%
1M Return1.44%
Value7.57
Score3/3
Weight40.85%
1M Return1.44%
Is MNDR undervalued or overvalued?
- MNDR scores 2.55/10 on fundamentals and holds a Premium valuation at present. Backed by its -100.17% ROE, -44.25% net margin, -0.26 P/E ratio, 0.34 P/B ratio, and 78.88% earnings growth, these metrics solidify its Underperform investment rating.
